3.15
急性呼吸不全の治療は、根本的な原因、全体的な健康状態、重症度などの要因によって異なります。早期発見のためにはたいてい、動脈血ガス分析と共同医療チームが不可欠です。原因の特定が主な目標であり、換気/灌流 (V/Q) の不均衡、シャント、または拡散障害に合わせて治療戦略を調整します。
呼吸状態の変化、動…
急性呼吸不全の管理には、協調的なアプローチが必要です。
呼吸療法は、酸塩基の不均衡に対処しながら、酸素化と換気を最適化することを目的としています。
呼吸不全の重症度に合わせて酸素投与を調整し、鼻カニューレやベンチュリーマスクなどの低流量デバイスから始めてください。ただし、反応のない患者は人工呼吸器が必要になる場合があります。
次に、薬物療法には、気管支痙攣と炎症を緩和するための静脈内コルチコステロイドによる短時間作用型気管支拡張薬が含まれます。静脈内利尿薬は肺のうっ血を緩和するために投与されますが、抗生物質は感染症と戦うために使用されます。
激しい咳、胸部理学療法、必要に応じて吸引などの技術を採用して、保持されている肺分泌物を効果的に動員します。
さらに、ネブライザーを介して滅菌生理食塩水または粘液溶解薬のエアロゾルを使用した加湿は、分泌物の管理に役立ちます。
禁忌でない限り、毎日2〜3リットルの水分補給を奨励して、分泌物を薄く保ち、除去を容易にします。.
最後に、栄養サポートには、カロリーニーズを決定し、回復のために十分なタンパク質、炭水化物、脂肪、ビタミンの摂取を確保することが含まれます。
View the full transcript and gain access to JoVE Core videos
Q1: What oxygen delivery methods are used to treat acute respiratory failure?
Oxygen therapy begins with low-flow devices like nasal cannulas at 1-2 L/min or Venturi masks at 24-28% oxygen concentration for responsive patients. Unresponsive patients or those with severe hypoxemia require mechanical ventilation with higher oxygen concentrations. Device selection depends on the patient's respiratory status, ability to maintain an open airway, and capacity to breathe spontaneously.
Q2: How do bronchodilators and corticosteroids help manage acute respiratory failure?
Short-acting bronchodilators relax lung muscles and expand airways, promoting easier breathing and improved respiratory function. Intravenous corticosteroids reduce airway inflammation and bronchospasm. Together, these medications address the underlying airway obstruction and inflammatory response, facilitating better oxygenation and ventilation in acute respiratory failure.
Q3: What techniques mobilize retained secretions in respiratory failure patients?
Effective secretion management combines vigorous coughing, chest physiotherapy with percussion and vibration, and suctioning through nasal or oral catheters. Humidification using aerosols of sterile normal saline or mucolytic drugs via nebulizer prevents secretion drying. Adequate hydration of 2-3 liters daily thins secretions, facilitating removal and promoting ciliary clearance.
Q4: Why is nutritional support critical in acute respiratory failure management?
Adequate nutrition supports immune function, wound healing, and preserves respiratory muscle strength. Calorie intake must be personalized to avoid overfeeding, which increases carbon dioxide production and oxygen consumption. Sufficient protein prevents muscle wasting, while micronutrients like Vitamin C, Vitamin D, Zinc, and Selenium enhance immune response and recovery.
Q5: What role do antibiotics and diuretics play in treating acute respiratory failure?
Antibiotics combat bacterial infections that may cause or complicate acute respiratory failure. Intravenous diuretics alleviate pulmonary congestion by eliminating excess fluid in the lungs, improving oxygenation and ventilation. Drug selection depends on identifying the underlying cause and addressing specific infection types or fluid overload conditions.
Q6: How does continuous monitoring guide treatment decisions in acute respiratory failure?
Continuous monitoring tracks respiratory status changes, arterial blood gas trends, and clinical improvement signs. Arterial blood gas analysis identifies acid-base imbalances and hypoxemia severity, guiding oxygen therapy adjustments. Collaborative healthcare teams use this data to tailor respiratory support, drug therapy, and interventions based on patient response.
Q7: What preventive nursing strategies support acute respiratory failure recovery?
Positioning patients upright or in tripod position promotes airflow and secretion drainage. Early ambulation when feasible enhances respiratory function and prevents complications. Proper patient positioning, combined with techniques from pneumonia nursing management and prevention, reduces infection risk and supports overall recovery in acute respiratory failure.